glp-1 prescriptions q1 2025 growth Nutritional Support Market Size & Share 2025-2035 GLP-1 RA prescription trends: January
Description
CrossRef Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease Kyung-Soo Kim, Byung-Wan Lee Clinical and Molecular Hepatology.2020
GLP-1 receptor agonists and heart failure in diabetes
A recent open label trial compared the efficacy of drugs currently used to lower ICP in IIH (amiloride, furosemide, spironolactone and topiramate) and found a marginal reduction in ICP with no difference between drugs [11]
Consistently taking the medication as directed is essential for achieving the desired results
